Total population | |
---|---|
N | 10 932 |
Sudden cardiac death cases | 419 (4%) |
Age (years) | 65.2±9.6 |
Men | 4638 (42%) |
Body mass index (kg/m2) | 26.9±4.1 |
Blood pressure (mm Hg) | |
Systolic | 138±21 |
Diastolic | 77±12 |
Smoking | |
Past | 4942 (45%) |
Current | 2461 (23%) |
Total cholesterol (mmol/L) | 6.2±1.2 |
QTc interval (ms) | 432±25 |
Heart rate (bpm) | 70±12 |
Prevalent coronary heart disease | 751 (7%) |
Prevalent heart failure | 257 (2%) |
Prevalent atrial fibrillation | 449 (4%) |
Estimated glomerular filtration rate (mL/min/1.73 m2)* | 79.4±16.4 |
Digoxin use at baseline | 229 (2%) |
Digoxin use during follow-up | 971 (9%) |
Allele frequencies | |
1236 C | 0.57 |
2677 G | 0.56 |
3435 C | 0.47 |
Haplotype frequencies† | |
CGC | 0.41 |
TTT | 0.41 |
Other | 0.18 |
Data presented as number (percentage) or mean±SD.
*Total study population for this variable n=10 051, sudden cardiac death cases n=356.
†Total study population for this variable n=5089, sudden cardiac death cases n=332.QTc, heart rate corrected QT interval according to Bazett's formula.